ANTI-INHIBITOR COAGULANT COMPLEX
Semantic Scholar uses AI to extract papers important to this topic.
Objectives:We report a case of a patient receiving dabigatran who developed a life-threatening bleeding complication during… Expand Edoxaban, an oral, direct factor Xa inhibitor, has a similar or low incidence of bleeding events compared with other… Expand The development of inhibitory antibodies to factor VIII is a serious complication of hemophilia. FEIBA (factor VIII inhibitor… Expand Summary. In haemophilia patients with inhibitor, elective orthopaedic surgery is usually performed under recombinant activated… Expand Summary. Recombinant factor (rF)VIIa has been available to clinicians since 1996 and has an excellent safety record after almost… Expand Summary. Thrombosis is a rare but well‐recognized potential complication of Factor VIII Inhibitor Bypass Activity (FEIBA… Expand Summary. Haemorrhagic manifestations in patients with acquired haemophilia can be fatal if not recognized and treated… Expand Factor VIII (FVIII)-bypassing agents have complex modes of action but all control bleeding in inhibitor patients by triggering… Expand UNLABELLED
Melagatran is the active form of the oral, direct thrombin inhibitor H 376/95. In several animal models of thrombosis… Expand Factor VIII or factor IX replacement is frequently impossible in inhibitor-developing hemophiliacs, because of the level of the… Expand